Related by context. All words. (Click for frequent words.) 70 Iluvien ® 69 Medidur 66 Retisert 65 Iluvien TM 64 intravitreal insert 63 ILUVIEN ® 63 delivers fluocinolone acetonide FA 62 alvimopan 62 diabetic macular edema DME 62 Medidur TM FA 61 VEGF Trap 61 Anturol 61 injectable formulation 61 PROMACTA 61 Phase IIa trial 61 Ozurdex 61 diabetic macular edema 61 Zelrix 60 Relivar 60 Dacogen injection 60 Locteron 60 ocular hypertension 60 Civacir 60 methylnaltrexone 60 Emezine 60 voclosporin 60 thymalfasin 60 T Pred 60 Phenoptin 59 Ferumoxytol 59 Zenvia ™ 59 Phase Ib 59 BLA submission 59 FAME Study 59 Nebido 59 pivotal Phase III 59 Evicel 59 pegloticase 59 sNDA submission 59 CINTREDEKIN BESUDOTOX 59 Phase 2b clinical 59 microplasmin 59 BEMA TM Fentanyl 59 Dabigatran etexilate 59 Increlex R 59 Firazyr 59 Fodosine 59 QNEXA 59 Mepact 59 phase IIb clinical 59 BAY #-# 59 Plenaxis TM 59 acetonide FA 59 Increlex ® 59 topical formulation 59 DC Bead 58 Amrubicin 58 Diabetic Macular Edema 58 Dupuytren Contracture 58 VEGF inhibitor 58 Phase 2b trial 58 ATryn R 58 Indaflex TM 58 confirmatory Phase III 58 Junovan 58 Rescula 58 ruxolitinib 58 investigational drug 58 Sanvar R 58 Horizant 58 Combidex 58 AzaSite Plus 58 eltrombopag 58 histone deacetylase HDAC inhibitor 58 ALN TTR# 58 Gabapentin GR 58 albinterferon alfa 2b 58 EOquin 58 ONGLYZA ™ 58 active comparator 58 Augment Bone Graft 58 CoFactor 58 MAA submission 58 Icatibant 58 JAK inhibitor 58 Phase IIb trial 58 intravenous acetaminophen 58 AzaSite 58 Kynapid 58 HZT 58 INCB# [002] 58 SUMAVEL 58 lucinactant 57 Virulizin R 57 INT# [002] 57 vinorelbine tartrate 57 aflibercept 57 Aurexis 57 Dalbavancin 57 L BLP# 57 Phase III pivotal 57 Empatic 57 Phase IIb 57 TELINTRA 57 Increlex TM 57 Anturol ® 57 Stedivaze 57 Microplasmin 57 TYZEKA 57 ARCOXIA 57 REPEL CV 57 Cellegesic 57 Plenaxis R 57 Besivance 57 Amigal 57 Phase 2b study 57 Clolar ® 57 TRANSDUR Sufentanil 57 Xyrem ® 57 elagolix 57 Xiaflex 57 regadenoson 57 LEUKINE 57 MAP# 57 Entereg R 57 Diabetic Macular Edema DME 57 Increlex 57 Excellarate TM 57 subcutaneous formulation 57 TYGACIL 57 fenofibric acid 57 CORTOSS 57 ATryn ® 57 Probuphine 57 GALNS 57 Fibrillex TM 57 Onrigin 57 AZX# 57 BYDUREON 57 denufosol 57 Solzira 57 Vernakalant 57 subcutaneously administered 57 PREOS R 57 nalbuphine ER 57 GEM #S 57 Phase III clinical 57 gabapentin enacarbil 57 DepoDur TM 57 TheraCIM 57 lorvotuzumab mertansine 57 NEBIDO 57 Zirgan 57 GAMMAGARD 57 CRMD# 57 Anturol TM 57 oral methylnaltrexone 57 Dyloject TM 57 HuMax CD4 57 topical NSAID 57 rilonacept 57 IMGN# 57 liposomal formulation 57 PrevOnco 57 PDX pralatrexate 57 ZEGERID Capsules 57 Marqibo 57 Cerashield 57 Relistor 57 Bronchitol 57 targeted radiotherapeutic 57 HCV protease inhibitor 56 PREOS 56 SinuNase TM 56 Excellagen 56 Sumavel DosePro 56 Topical Interferon Alpha 2b 56 Nexavar ® 56 oral ridaforolimus 56 SNT MC# 56 MAGE A3 ASCI 56 ENTEREG ® 56 PEG Interferon lambda 56 somatostatin analogue 56 Removab 56 FIRAZYR 56 Fibrin Pad 56 Onalta 56 Zingo TM 56 MoxDuo IR 56 Orapred ODT 56 Tarceva TM 56 Chemophase 56 DexaSite 56 OncoGel 56 Proleukin 56 Pirfenidone 56 Phase 2a 56 Aryplase 56 Exalgo 56 Soliris eculizumab 56 ALGRX 56 Soliris TM eculizumab 56 valopicitabine 56 dirucotide 56 Corlux 56 BrachySil 56 Phase III clinical trials 56 ZYBRESTAT 56 Glybera R 56 Phase 2a trial 56 phase IIa clinical 56 Hycamtin 56 bicifadine 56 prGCD 56 GAMMAGARD LIQUID 56 Deferiprone 56 Onalta ™ 56 TORISEL 56 Argatroban 56 Arcalyst 56 ORENCIA ® 56 overactive bladder AA# 56 HFA MDI 56 RSD# oral 56 Phase III confirmatory 56 Ketotransdel 56 NOXAFIL 56 OncoVEX GM CSF 56 Prolacria 56 Azedra 56 RG# [001] 56 TELCYTA 56 FACTIVE R gemifloxacin 56 Nimotuzumab 56 Zenvia TM 56 PEG PAL 56 docetaxel Taxotere ® 56 AGGRASTAT R 56 Firdapse 56 tezampanel 56 NUVIGIL 56 Bicifadine 56 Allovectin 7 56 Zalbin 56 pseudobulbar affect PBA 56 Aerosurf 56 alogliptin 56 Vilazodone 56 PDE4 inhibitor 56 vapreotide acetate 56 Oracea ® 56 Synvisc One 56 Octreotide 56 successfully commercialize Iluvien 56 Tezampanel 56 Evoltra 56 FOLOTYN ® 56 SinuNase 56 sorafenib tablets 56 Marketing Authorisation Application MAA 56 MYDICAR ® 56 ONTAK 56 mometasone furoate 56 Octreolin 56 CANCIDAS 56 Emselex 56 phase IIb 56 Trexima 56 severe hypercholesterolemia 56 COMFORT II 56 ZENPEP 56 topically applied SEPA 56 Rebif ® 56 efficacy tolerability 56 VIAject R 56 investigational 56 Exalgo TM 56 interferon beta 1b 56 Ilaris 56 Jevtana 56 apaziquone 56 Androxal TM 56 anidulafungin 56 Onsolis 56 taliglucerase alfa 56 KNS # 56 RhuDex ® 56 registrational 55 GlycoPEG GCSF 55 BEMA Fentanyl 55 KRYSTEXXA TM pegloticase 55 Advexin 55 Factor VIIa 55 ADVEXIN 55 TBC# 55 R sorafenib tablets 55 Golimumab 55 CIP TRAMADOL ER 55 opioid induced bowel dysfunction 55 miconazole Lauriad R 55 Zerenex 55 ONSOLIS 55 Filgrastim 55 Degarelix 55 Acetavance 55 liver resection surgeries 55 Ereska 55 Ventavis 55 confirmatory Phase 3 55 BRILINTA 55 GSK# [001] 55 postoperative ileus POI 55 PENNSAID 55 refractory APL 55 ITAX 55 Pafuramidine 55 TKM ApoB 55 Rezular 55 luliconazole 55 XIAFLEX 55 ZEGERID Powder 55 oral prodrug 55 VPRIV 55 Resten NG 55 methylnaltrexone bromide 55 SPARLON 55 Uplyso 55 Iloperidone 55 novel prodrug 55 TAXUS Element Stent System 55 ALN VSP 55 Tyvaso 55 ABILIFY R 55 octreotide acetate 55 sumatriptan DosePro 55 trastuzumab DM1 T DM1 55 diabetic neuropathic pain 55 DepoDur 55 Orphan Drug designation 55 Noxafil 55 Rectogesic 55 Syncria 55 Adlea 55 ALVESCO HFA 55 budesonide foam 55 Promacta 55 Raptiva ® 55 Targretin 55 Fast Track designation 55 registrational trial 55 VIAdel TM technology 55 thrombin inhibitor 55 REPLAGAL 55 Altropane 55 Omigard 55 Inhalation Solution 55 TEMODAL 55 octreotide implant 55 SAR# [004] 55 Egrifta 55 dalbavancin 55 amrubicin 55 Plicera 55 FENTORA 55 Bezielle 55 OFIRMEV 55 Ceflatonin 55 ATL# [001] 55 Loramyc ® 55 OncoVEX 55 INC# 55 Traficet EN 55 severe gastroparesis 55 Glufosfamide 55 TRISENOX 55 Northera 55 Rilonacept 55 Ixempra 55 Orphan Status 55 TREANDA 55 Cloretazine R VNP#M 55 OLEPTRO TM 55 non metastatic osteosarcoma 55 Juvista 55 reslizumab 55 refractory Hodgkin lymphoma 55 Irinotecan 55 NP2 Enkephalin 55 BioSTAR R 55 Efficacy Results 55 Loramyc R 55 MEPACT 55 Tamibarotene 55 Navelbine ® 55 Cethrin 55 Zenpep 55 Ruconest 55 AeroLEF TM 55 tanespimycin 55 herpetic keratitis 55 brivaracetam 55 Exelbine 55 Cardiac Cryoablation System 55 placebo controlled Phase 55 Plasmin 55 ezogabine 55 ULTRASE 55 Bepreve 55 selective androgen receptor modulator 55 rHuPH# recombinant human 55 Entereg 55 Neo Urinary Conduit 55 KRN# 55 hoFH 55 GTC recombinant human 55 L MTP PE 55 Ophena TM 55 dermal patch 55 R bendamustine hydrochloride 55 Abstral 55 docetaxel Taxotere R 55 tafamidis 55 clinical trial 55 Eluting Coronary Stent System 55 BLA filing 55 PrevOnco ™ 55 mipomersen 55 PEP# [003] 55 diarrhea predominant irritable 55 New Drug Application 55 LEVADEX 55 proprietary transdermal patch 55 Marketing Authorisation Application 55 Dyloject 55 Zorbtive TM 55 generation purine nucleoside 55 CIP ISOTRETINOIN 55 XIBROM 55 Kuvan 55 pralatrexate 55 PRISTIQ 55 acyclovir Lauriad ® 54 StemEx 54 crofelemer 54 NeuroStar TMS Therapy 54 Allovectin 7 ® 54 exenatide 54 ELIQUIS 54 dextromethorphan quinidine 54 LUVENIQ 54 NGX# 54 CEQ# 54 AZILECT ® 54 RANK Ligand inhibitor 54 Marketing Authorization Application 54 IL# PE#QQR 54 ocular formulation 54 MoxDuo 54 pharmacokinetic PK study 54 XIAPEX 54 Oral NKTR 54 Neurodex 54 interferon gamma 1b 54 RELISTOR 54 palonosetron 54 STELARA TM 54 FIRMAGON R 54 mertansine 54 XIAFLEX ™ 54 Cardio Vascu Grow 54 Trobalt 54 Orphan Drug Status 54 BEMA Granisetron 54 YONDELIS 54 Alvesco R 54 Fludara 54 dabigatran etexilate 54 ISENTRESS 54 SILENOR TM 54 TRISENOX ® 54 Tibotec Therapeutics division 54 BrachySil TM 54 Topotecan 54 CCX# 54 SUTENT ® 54 Leukine ® 54 selective A2A adenosine receptor 54 Epoetin alfa 54 BRIM2 54 Orphan Drug designations 54 MabCampath 54 Inhalation Aerosol 54 HspE7 54 SYCREST 54 Pennsaid R 54 Viprinex 54 Valtropin 54 Teysuno 54 Triolex 54 obatoclax 54 canakinumab 54 Xcytrin 54 Gamunex C 54 Intermezzo R 54 novel oral anticoagulant 54 PS# [001] 54 cannabinor 54 TYKERB 54 BROMDAY 54 Proxinium TM 54 orphan designation 54 IV acetaminophen 54 etanercept Enbrel 54 CRx 54 noninfectious uveitis 54 Advagraf 54 Retacrit 54 Toctino ® alitretinoin 54 Hyphanox 54 UPLYSO 54 Kamada AAT 54 forodesine 54 MYDICAR 54 Phase III Clinical Trial 54 Investigational Device Exemption IDE 54 PROMUS Element Stent 54 ICA # 54 Veronate 54 XIAFLEX ® 54 Amyvid 54 RHUCIN 54 Genasense 54 Omigard TM 54 NVA# 54 Vicinium TM 54 balsalazide tablet 54 RSD# iv 54 sNDAs 54 iloperidone 54 satraplatin 54 Kepivance 54 riociguat 54 Actimmune ® 54 CCR5 mAb 54 tasocitinib 54 APF# 54 Joulferon 54 zonisamide SR 54 Macugen 54 Sanvar 54 Dapagliflozin 54 daclizumab 54 KRYSTEXXA 54 recombinant thrombin 54 ceftobiprole 54 Mipomersen 54 Aloxi R 54 Rhucin ® 54 IRX 2 54 phase IIa 54 amifampridine phosphate 54 CLARITY study 54 Cethromycin 54 HepeX B 54 EOquin TM 54 BEMA TM LA 54 motexafin gadolinium Injection 54 ketolide antibiotic 54 Phase IIIb 54 glufosfamide 54 topical formulations 54 Aztreonam 54 oxymorphone ER 54 Chrysalin 54 vernakalant hydrochloride 54 recombinant human 54 ThermoDox ® 54 OPAXIO 54 Frova R 54 Phase IIIb clinical 54 teriflunomide 54 metaglidasen 54 LEVADEX TM 54 Tasigna nilotinib 54 maribavir 54 Somatuline Depot 54 synthetic retinoid 54 Complete Response 54 Voltaren Gel 54 IIa trial 54 Phase 1b trial 54 Ranexa 54 Loramyc 54 ularitide 54 tamibarotene 54 IMA# 54 Zolpimist 54 Flutiform TM 54 torezolid phosphate 54 OMNARIS HFA 54 Panzem R 54 Vitrasert R 54 FavId 54 Oracea TM 54 double blinded placebo 54 Mozobil 54 Xolegel 54 BEMA Buprenorphine 54 Xcytrin R 54 Pivotal Trial 54 Voraxaze 54 Rhucin 54 Clonicel 54 Fx #A 54 omacetaxine mepesuccinate 54 investigational monoclonal antibody 54 DAVANAT 54 Ciclesonide 54 GEM OS1 54 Catena ® 54 Prosaptide 54 Polymer Microspheres 54 IONSYS TM 54 highly purified pasteurized 54 romidepsin 54 Teflaro 54 non alcoholic steatohepatitis 54 Galvus 54 Linjeta TM 54 #D#C# 54 OvaRex R 54 Q#IR 54 Naglazyme 54 MOZOBIL 54 MOVIPREP R 54 Ramelteon 54 NDA submission 54 Phase IIa 54 Phase #b/#a trial 54 buccal insulin spray 54 linaclotide 54 antiplatelet agent 54 vandetanib 54 Eliquis 54 BLP# Liposome Vaccine 54 AFREZZA 54 Mycamine 54 Sycrest 53 ProSavin 53 antisense drug 53 Azixa 53 celgosivir 53 intranasal formulation 53 ecallantide 53 Ganciclovir 53 rFVIIa 53 Campath 53 DAVANAT R 53 MyVax R 53 Anticalin R 53 Onco TCS 53 TOLAMBA 53 Phase IIa clinical 53 RAPTIVA 53 Sular formulation 53 rNAPc2 53 lubiprostone 53 STRIDE PD 53 Evoltra ® 53 ONCASPAR 53 miconazole Lauriad 53 mild vasodilator 53 Desmoteplase 53 Luveniq 53 Phase IIb clinical trials 53 elotuzumab 53 huC# DM4 53 DB# [003] 53 ALVESCO R 53 arsenic trioxide injection 53 release intravitreal insert 53 intravenous formulation 53 Pivotal Phase III 53 Peginterferon alfa 2b 53 Luteinizing Hormone Releasing Hormone 53 CYCLOSET 53 Bydureon 53 NUEDEXTA ™ 53 Initiate Clinical Trial 53 exenatide once 53 HP Acthar Gel repository 53 silodosin 53 Forsteo 53 Phase III trials 53 lurasidone 53 BAL# [002] 53 ELADUR 53 relapsing multiple sclerosis 53 Phase Ib clinical trials 53 Rapaflo 53 PNP inhibitor 53 actinic keratosis 53 XGEVA 53 Keppra R 53 masked placebo controlled 53 Onbrez Breezhaler 53 Phase IIb clinical 53 pradefovir 53 ARIKACE ™ 53 Vivaglobin 53 EVIZON 53 Torisel 53 Serdolect ® 53 Alzhemed TM 53 Microcyn Technology 53 Glybera 53 LEP ETU 53 telbivudine 53 lacosamide 53 phase IIb trial 53 Reverset 53 Epratuzumab 53 dacetuzumab 53 PLK1 SNALP 53 inhaled formulation 53 DORIBAX 53 Brilique 53 HCD# [002] 53 Safinamide 53 oncology indications 53 pharmacokinetic PK 53 Ozarelix 53 METOZOLV ODT 53 clinical trials 53 EcoNail 53 Phase 1b 53 Aztreonam lysine 53 RECOTHROM R 53 systemic immunosuppressive drugs 53 Drug Eluting Stent System 53 Luvox CR 53 Ceplene 53 phase IIb study 53 Sanctura XR 53 talactoferrin 53 DR Cysteamine 53 FOLOTYN 53 gadobutrol 53 Saforis 53 HepaSphere 53 daptomycin 53 interferon alfa 53 RSD# 53 Levoleucovorin 53 etravirine 53 CryoSeal FS System 53 investigational humanized monoclonal antibody 53 prodrug 53 BARACLUDE R 53 Aflibercept 53 prospective multicenter 53 PEG INTRON 53 Biologics License Application BLA 53 LAF# 53 Zenvia 53 Cannabinor 53 Vitaros 53 cintredekin besudotox 53 EmbraceAC 53 Xibrom TM 53 Zavesca r 53 Xenazine ® 53 alemtuzumab MS 53 phase III isavuconazole 53 Milnacipran 53 Biological License Application 53 topical gel 53 Cushing Syndrome 53 SAPHRIS 53 vidofludimus 53 Biologics License Application 53 randomized multicenter 53 Strativa 53 Aclasta 53 XmAb# 53 CA4P 53 Junovan TM 53 Onrigin TM 53 perifosine 53 SPD# 53 PegIntron 53 Restanza 53 Varisolve 53 Frova ® 53 ferumoxytol Injection 53 Crofelemer 53 SUMAVEL DosePro 53 pharmacologic stress agent 53 Cinryze TM 53 BYETTA ® 53 MNTX 53 tolevamer 53 HuMax EGFr 53 Sandostatin LAR 53 IV APAP 53 PROCRIT ® 53 BiovaxID TM 53 XL# anticancer compounds 53 Albugon 53 Troxatyl 53 Fablyn 53 Levetiracetam 53 HuMax CD# 53 Clolar 53 diquafosol tetrasodium 53 SIR Spheres 53 PXD# 53 Sensipar 53 afamelanotide 53 ocrelizumab 53 Daytrana ® 53 motavizumab 53 PREZISTA r 53 Personalized Immunotherapy 53 Ketotransdel ® 53 ancrod 53 EndoTAG TM -1 53 Telaprevir 53 Nabi HB Intravenous 53 ataluren 53 INCB# [001] 53 LymphoStat B belimumab 53 sulodexide 53 Phase 2b 53 Abbokinase 53 NDA Submission 53 vilazodone 53 ZOLINZA 53 paliperidone palmitate 53 IND submission 53 painful diabetic neuropathy 53 valdecoxib 53 AEG# 53 OMNARIS 53 topical antifungal 53 Telzir 53 Vimpat R 53 OvaRex ® MAb 53 TOCOSOL Paclitaxel 53 Tracleer R 53 postoperative ileus 53 Cycloset 53 candidate REP# 53 oral calcitonin 53 Pruvel 53 acyclovir Lauriad R 53 Nexavar sorafenib 53 pain palliation 53 ENRICH trial 53 Privigen 53 LidoPAIN SP 53 T DM1 53 Satraplatin 53 PRIALT 53 Surfaxin LS 53 Treanda 53 TG# [003] 53 MKC# MKC# PP 53 Abiraterone acetate 53 COLAZAL 53 Adhesion Barrier 53 Nuedexta 53 Neupro R 53 atrasentan 53 Sebivo 53 Ecallantide 53 TMC# C# 53 Navelbine 53 novel VDA molecule 53 ozarelix 53 filgrastim 53 dose escalation clinical 53 asenapine 53 velaglucerase alfa 53 Phase IIa trials 53 Arxxant 53 Archexin 53 ZYBRESTAT fosbretabulin 53 MONOVISC 53 Cladribine Tablets 53 Viibryd 53 Sym# 53 dose escalation trial 53 vascular disrupting agent 53 dermaPACE TM 53 citalopram hydrobromide 53 oral rivaroxaban 53 Convivia TM 53 Tygacil 53 APTIVUS r 53 LB# [003] 53 torsemide ER 53 CIMZIA ™ 53 non nucleoside inhibitor 53 Qnexa 53 refractory chronic lymphocytic 53 EGS# 53 Sanctura 53 VIMOVO 52 Afinitor 52 StaphVAX R 52 DermaVir Patch 52 atacicept 52 icatibant 52 heterozygous FH 52 rFVIIIFc 52 milnacipran 52 Synavive 52 Azedra TM 52 lintuzumab 52 CB2 selective receptor agonist 52 Exherin TM 52 JANUVIA 52 orBec R 52 OROS R Hydromorphone 52 nephropathic cystinosis cystinosis 52 Zenvia Phase III 52 Ganite R 52 Ofatumumab 52 faropenem medoxomil 52 ixabepilone 52 ABRAXANE ® 52 FDA Approvable Letter 52 Clevudine 52 FTY# 52 ALN PCS 52 MERLIN TIMI 52 Ophena 52 investigational pharmacologically unique 52 edoxaban 52 sevelamer carbonate 52 TroVax ® 52 lumiliximab 52 virus HCV protease inhibitor 52 Qutenza TM 52 volociximab 52 XL# XL# XL# 52 Captisol Enabled 52 ATL# [002] 52 FOSRENOL 52 Pegintron 52 Ketotransdel TM 52 nasal calcitonin product 52 Aclidinium 52 TRANSDUR ™ 52 mifamurtide 52 oral salmon calcitonin 52 Abbott Laboratories Depakote 52 CD# monoclonal antibody 52 Tekamlo 52 Perifosine 52 Linaclotide 52 IND enabling 52 Arikace 52 Fortigel 52 zalutumumab 52 blinded randomized placebo controlled 52 Candesartan 52 Gelnique 52 Kuvan sapropterin dihydrochloride 52 miconazole Lauriad ® 52 Rapydan 52 Cimzia TM 52 fluvoxamine maleate 52 DPP4 52 blinatumomab 52 ALN TTR 52 intravenous formulations 52 Amplimexon 52 AERx iDMS 52 LE SN# 52 Ganite ® 52 injectable enzyme 52 sumatriptan injection 52 BiovaxID 52 HepeX B TM 52 SEBIVO 52 Combunox 52 Phase Ib study 52 Vimpat 52 peginesatide 52 Fast Track Status 52 Biologic License Application BLA 52 Kuvan TM sapropterin 52 rhThrombin 52 Actemra tocilizumab 52 AFRESA 52 ofatumumab